James L. Tyree - 26 May 2022 Form 4 Insider Report for ChemoCentryx, Inc.

Role
Director
Signature
/s/ Susan M. Kanaya, as Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
26 May 2022
Net transactions value
$0
Form type
4
Filing time
31 May 2022, 21:39:15 UTC
Previous filing
24 May 2022
Next filing
13 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CCXI Restricted Stock Units Award +15,723 15,723 26 May 2022 Common Stock 15,723 Direct F1, F2
transaction CCXI Stock Option (right to buy) Award +8,342 8,342 26 May 2022 Common Stock 8,342 $22.39 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of CCXI common stock.
F2 The restricted stock units awarded on May 26, 2022, vests on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Company on such date. Shares will be delivered to the Reporting Person within thirty (30) days following the vesting date.
F3 The option granted on May 26, 2022, vests on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Company on such date.
F4 Not applicable.